JW PHARMACEUTICAL
001060 | KO
Overview
Corporate Details
- ISIN(s):
- KR7001060003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 과천시 과천대로7길 38 -, 과천시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 3.1 MB | ||
| 2025-07-31 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-31 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 30.7 KB | ||
| 2025-07-02 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 62.4 KB | ||
| 2025-07-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.8 KB | ||
| 2025-06-25 00:00 |
Transaction in Own Shares
자기주식취득결과보고서
|
Korean | 62.4 KB | ||
| 2025-06-13 00:00 |
Legal Proceedings Report
벌금등의부과
|
Korean | 5.9 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 928.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.4 MB | ||
| 2025-05-07 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-04-21 00:00 |
Management Reports
기업가치제고계획(자율공시) (2025년)
|
Korean | 7.5 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 40.6 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 109.2 KB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 29.5 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.8 KB |
Automate Your Workflow. Get a real-time feed of all JW PHARMACEUTICAL filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for JW PHARMACEUTICAL
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for JW PHARMACEUTICAL via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
United Kingdom
ANAN
Türkiye
ANGEN
Developing precision therapeutics for neurodegenerative and CNS disorders.
United States of America
AVXL
United States of America
AVXL
Develops and supplies in vitro diagnostic solutions for human and veterinary markets.
United States of America
NNNN
United States of America
NNNN
Clinical-stage biotech developing an antidote for acute cannabinoid intoxication in ER patients.
United States of America
ANEB
United States of America
ANEB
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan
4563
Japan
4563
Develops joint preservation and regenerative solutions for early intervention orthopedic care.
United States of America
ANIK
United States of America
ANIK
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom
ANCR
United Kingdom
ANCR
Develops, manufactures, and markets branded/generic drugs and OTCs for niche therapeutic areas.
United States of America
ANIP
United States of America
ANIP
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden
ANNX
Sweden
ANNX